We offers a comprehensive Tumor Model Portfolio Service designed to streamline functional CAR-T screening and accelerate immunotherapy drug discovery. Our integrated platform combines high-fidelity 3D tumor organoids, syngeneic mouse models, and humanized systems to address poor in vitro–in vivo correlation and high attrition in solid tumor targeting. By enabling systematic...
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Ελληνικά
Tiếng Việt